ATON
LIVE

Serial Number

79396488

Owner

HYBRIGENICS SA

Attorney

Jeffrey H. Handelsman

Filing Date

Dec 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ATON Trademark

Serial Number: 79396488 • Registration: 7749376

ATON is a trademark filed by HYBRIGENICS SA on December 8, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HYBRIGENICS SA (12 trademarks)

3/5 Impasse Reille

Entity Type: 99

Trademark Details

Filing Date

December 8, 2023

Registration Date

April 8, 2025

Published for Opposition

February 18, 2025

Goods & Services

Chemical products, namely, chemical additives, chemical active ingredients, chemical solvents, chemical reagents, chemical preservatives, chemical antioxidants, ethylene oxide, ethylene glycol, chlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic use, namely, for scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes intended for the biotechnology industry

Pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; veterinary products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological, biochemical and biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics

Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveying, namely, engineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studies, research and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial research, fine tuning industrial processes, namely, troubleshooting of industrial process control computer software problems, data automation using proprietary software to evaluate, analyze and collect service data, professional scientific consultancy, material testing, scientific laboratory services, and computer programming, all these services being dedicated to biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomics, proteomics, protein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service [PaaS] featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bank, namely, data warehousing

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 15, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 29, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 29, 2025 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Oct 25, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 24, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 9, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 27, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 27, 2025 COAR
REFUSAL PROCESSED BY IB
Aug 25, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 10, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 30, 2024 REPR